GRAND RAPIDS - Van Andel Research Institute and Dako, the Danish-based, worldwide supplier of cancer diagnostic tools, Wednesday announce an agreement to license, manufacture and distribute cancer diagnostics utilizing the MET4 Antibody. The MET4 Antibody, developed by George F. Vande Woude, Ph.D. and Brian Cao, M.D. of VARI and Beatrice Knudsen, M.D., Ph.D., formerly of
ANN ARBOR - Michael Stebbins, assistant director for biotechnology in the White House Office of Science and Technology Policy, provided members of MichBio a glimpse of a new bioeconomy program scheduled to be unveiled in Washington next week. Speaking at the trade group?s annual meeting, Stebbins reportedly said the administration is working to do whatever
GRAND RAPIDS ? Researchers in Sweden have discovered a new stem cell in the adult brain that can proliferate and form new brain cells. Van Andel Research Institute scientists hope to take advantage of the finding to develop methods to heal and repair disease and injury in the brain. Analyzing brain tissue from biopsies, the
ANN ARBOR ? A team from the University of Michigan, has helped deliver stem cells into the spines of patients with Lou Gehirg's disease, opening the door to a new treatment. In a paper published online ahead of print publication in the peer-reviewed journal Stem Cells, a team from the U-M, Emory University and study
PLYMOUTH - Esperion Therapeutics announced the appointment of Noah Rosenberg, MD, as its chief medical officer. Dr. Rosenberg will lead the Esperion clinical advisory board and will develop and manage the company's clinical programs. He will also manage the regulatory review process for the company's innovative investigational therapies to prevent, treat and reverse cardiovascular and
ANN ARBOR - Dean Baker, the former GM Body-in-White Chief Manufacturing Engineer, is a new principal at Fulcrum Edge. Baker holds a Bachelor of Science degree in Electrical Engineering from General Motors Institute (Kettering University), a Masters degree in Electrical Engineering from the University of Michigan, and is certified as a Project Management Professional by
PLYMOUTH - Esperion Therapeutics announced positive results from a Phase 2 clinical trial for ETC-1002, an LDL cholesterol lowering drug. This small molecule activator of AMP Kinase has demonstrated preclinical and clinical activity as a metabolic regulator of imbalances in lipid and carbohydrate metabolism. Results were presented Tuesday in an oral presentation at the 2012
ANN ARBOR - MichBio has named Wendy Wendel (formerly Wendy Ventura) as the Director, Marketing & Communications. In this role, she will oversee the planning and execution of the association?s marketing, communications, public relations and social media efforts. Prior to joining MichBio, Wendy served as the Director, Marketing for The Engineering Society of Detroit, a
LIVONIA - Michael Stebbins, PhD, a life sciences and biotech advisor to President Barrack Obama, is the keynote speaker at the MichBio 2012 Annual Business Meeting April 19 at Schoolcraft College. Stebbins is Asst. Director-Biotechnology, Science Division White House Office of Science & Technology Policy Executive Office of the President. He previously served as a
ANN ARBOR - Rubicon Genomics announced that it has selected Kalamazoo-based Velesco Pharmaceutical Services to manufacture the TransPLEX kits it will be supplying for use with Agendia's breast cancer diagnostics. Terms of the agreement were not disclosed. Velesco is a provider of analytical method development, drug formulation, stability testing and consulting services to biotech and